Abstract Submission Rules | EMIM 2026

Check submission rules carefully, before proceeding to the submission system!

26-29 January: Call for Late-Breaking Submissions!

Quick reminder, that…
  • The number of submissions as presenting author is limited to one (no limit on co-authorship).
  • The overall number of submissions is limited to the top scored 750.
  • You have to confirm that the work has not been published yet (at the time of the submission deadline) and
  • was not presented at former EMIMs.

Submission Rules

  • all abstracts must be submitted via the online submission system (button below)
  • first time users (of the EMIM 2026 abstract system) need to create an account to enter the submission system
  • login data for earlier EMIMs or your member login are not valid for the EMIM 2026 submission system
  • make sure that your email address for the log-in is the same as for the actual submission (author email)
  • your abstract must be submitted to one of the abstract category (see below)
  • IMPORTANT! Make sure to provide data/figures to support your results & conclusion.
  • you strictly have to follow the scheme: 
    Introduction
    Methods
    Results/Discussion
    Conclusions
    Acknowledgement (optional)
    References (optional)
  • size limit: all in all 2850 characters (incl. space characters) divided into:
    Introduction: 600
    Methods: 800
    Results/Discussion: 1000
    Conclusion: 450
    + Novelty: 150
    + Impact: 150
  • you can add a maximum of two figures/pictures (jpeg, png) each with a limited size file of 2MB
  • application for the EMIM 2026 Young Investigator Award (check on eligibility criteria first here!) is possible during the submission process (only first deadline!)
  • you will be able to make changes on your submission until the submission deadline
  • all abstracts will be acknowledged upon receipt (subject: Abstract Transmission Report). If you do not receive an automated transmission report by email please contact the helpdesk or the ESMI office
  • notifications on acceptance and type of presentation (poster/talk) will be sent on 5 January 2026 at latest for abstracts submitted within the deadline 18 November.
Proceed to Submission System
Submitted an Abstract already?

For submissions received by 18 November, notification to all presenting authors were sent on 17 December 2025. If you have not received a notification please check your spam folder or contact us! It is recommended to add the domains @e-smi.eu and @esmi-insight.eu to your whitelist.

You can log-in into the submission system any time and check:

  • status of your submission (acceptance/oral/poster, day/time of presentation)
  • confirm your presentation
  • upload of digital poster
  • upload your presentation (available in March 2026)
  • withdraw or change the presenter of your submission.

Abstract Categories

Abstract categories per main (IN BOLD CAPITALS) category

Note that for 9 – In Vitro Models the main category = abstract category.

  1. PHYSICS, ENGINEERING & TECHNOLOGIES
    1. PET/SPECT, Hybrid Technologies
    2. MRI, MPI Technologies
    3. Optical Technologies
    4. Ultrasound, Optoacoustic Technologies
    5. X-Ray Technologies
    6. Spatial Tissue Omics (incl. MSI, Genomics)
  2. PROBE CHEMISTRY & REPORTER GENES
    1. PET/SPECT, X-Ray, CT
    2. MRI/MPI
    3. Optical, Optoacoustics, Ultrasound
    4. Theranostics, Multimodal Agents
  3. IMAGE DATA PROCESSING, ANALYSIS & MODELING
    1. Acquisition, Reconstruction & Processing
    2. Quantification & Analysis
    3. AI, Machine Learning, Data Modelling
  4. IMAGE-GUIDED THERAPY
    1. Image-Guided Drug Delivery
    2. Theranostic Applications
    3. Interventional & Surgical Imaging
  5. CARDIOVASCULAR & RESPIRATORY
    1. Cardiac Imaging
    2. Vascular Imaging
    3. Pulmonary Imaging
  6. CNS & PERIPHERAL NERVES
    1. Brain Structure & Receptors
    2. Brain Metabolism, Function & Perfusion
    3. Neuroimaging Tools in Disease Models
  7. ONCOLOGY
    1. Cancer Biology (incl. Metabolism) & Microenvironment
    2. Cancer Diagnosis
    3. Cancer Therapy (incl. Immunotherapy)
  8. IMMUNOLOGY, INFLAMMATION & INFECTION
    1. Immune System Dynamics
    2. Infection & Tissue Immunity
  9. IN VITRO MODELS
Technical support / Helpdesk 

For any technical enquiries in regards to the EMIM 2026 abstract submission please contact EventClass
+49 (351) 30900031
email to the helpdesk

Programme
Plenary Speakers
Abstract Submission
Presenter Guidelines
Registration
Travel & Visa Application
Awards & Grants
Committees
Reviewer
Exhibition & Industry
Scam Warning
A word on scientific level & Review process

The scientific level of submissions is traditionally very high. Scientific quality and originality of your work is the sole basis for a decision on acceptance and presentation type (oral/poster). Each abstract is reviewed by at least 12 independent reviewers in a double blind reviewing process along the following parameters:

  • Originality of Content
  • Soundness of Conclusion
  • Importance
  • Quality
  • Novelty
  • Impact